⌘K

Home/Filings/4/0001209191-18-043905

4//SEC Filing

Chaparro Rodolfo 4

Accession 0001209191-18-043905

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 4:47 PM ET

Size

5.3 KB

Accession

0001209191-18-043905

Insider Transaction Report

Form 4

Period: 2018-07-23

Cue Biopharma, Inc.CUE

Chaparro Rodolfo

EVP, Head of Immunology

Transactions

Award
Stock Option (right to buy)
2018-07-23+75,000→ 75,000 total
Exercise: $11.54Exp: 2025-07-23→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]This stock option grant becomes exercisable in eight semi-annual installments beginning July 23, 2018.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001724869

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 4:47 PM ET
Size: 5.3 KB

View on SEC.gov